Education
About Us
Working with TipRanks
Follow Us
James B. Tananbaum Insider Profile
11 Followers
James B. Tananbaum, Director, Ten Percent Owner at Kinnate Biopharma, holds 15.20M shares in Alumis Inc. (Ticker: ALMS), holds 0.00 shares in Kinnate Biopharma (Ticker: KNTE), holds 1.00K shares in Pardes Biosciences (Ticker: PRDS). Most recently, James B. Tananbaum Bought ― shares of Alumis Inc. on May 06, 2025 for an estimated value of 202.30K.
James B. Tananbaum Kinnate Biopharma (KNTE)Director, Ten Percent Owner
Kinnate Biopharma (KNTE)
Director, Ten Percent Owner
Ranked #95,369 out of 102,674 Corporate Insiders
Profitable Transactions
0 out of 4 Profitable Transactions
Average Return
-55.20%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that James B. Tananbaum holds in companies
Most Profitable Insider Trade
The most profitable trade made by James B. Tananbaum
James B. Tananbaum's Trading History
Kinnate Biopharma
Apr 05, 2024
―
Uninformative Sell
―
$0.00
Disc Medicine
Feb 09, 2021
Director, Ten Percent Owner
Uninformative Buy
15.00M
$285.43M
Quantum-Si
Jun 14, 2021
Director
Uninformative Buy
25.00M
$12.30M
Pardes Biosciences
Aug 31, 2023
―
Uninformative Sell
―
$2.16K
Alumis Inc.
May 06, 2025
Director, Ten Percent Owner
Informative Buy
202.30K
$62.77M
List of latest transactions for each holding click on a transaction to see James B. Tananbaum's performance on stock
You May Also Like
James B. Tananbaum insider profile FAQ
What is the percentage of profitable transactions made by James B. Tananbaum?
The percentage of profitable transactions made by James B. Tananbaum is 0%.
What is the average return per transaction made by James B. Tananbaum?
The average return per transaction made by James B. Tananbaum is -55.20%.
What stocks does James B. Tananbaum hold?
James B. Tananbaum holds: KNTE, IRON, QSI, PRDS, ALMS stocks.
What was James B. Tananbaum’s latest transaction?
James B. Tananbaum latest transaction was an Informative Buy of $202.30K.
What was James B. Tananbaum's most profitable transaction?
James B. Tananbaum’s most profitable transaction was an Informative Buy of ALMS stock on May 6, 2025. The return on the trade was -10.80%.
What is James B. Tananbaum's role in Kinnate Biopharma?
James B. Tananbaum's role in Kinnate Biopharma is Director, Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.